跳至主要内容
临床试验/CTRI/2020/11/029143
CTRI/2020/11/029143尚未招募未知

Impact of COVID 19 on the frequency, spectrum and outcomes of Guillain-Barré Syndrome in India: A Multicenter ambispective cohort study

AIIMS New delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Diagnosis of GBS confirmed by diagnostic criteria for GBS of the National Institute of Neurological Disorders and Stroke (NINDS) or one of the variants of GBS, including the MFS and overlap syndromes
  • 2. Hospital admission within 4 - weeks of the onset of weakness (or other symptoms attributed to GBS.

排除标准

  • 1. Subacute Inflammatory demyelinating neuropathy (SIDP)
  • 2. Toxic neuropathies
  • 3. Vasculitic neuropathies

研究者

发起方
AIIMS New delhi

相似试验